432 related articles for article (PubMed ID: 28381382)
1. The association of non-alcoholic fatty liver disease and metabolic syndrome in a Chinese population.
Lee SW; Lee TY; Yang SS; Peng YC; Yeh HZ; Chang CS
Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):176-180. PubMed ID: 28381382
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
[TBL] [Abstract][Full Text] [Related]
3. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
4. Relationship between hemoglobin levels and risk for suspected non-alcoholic fatty liver in Taiwanese adults.
Bai CH; Wu MS; Owaga E; Cheng SY; Pan WH; Chang JS
Chin J Physiol; 2014 Oct; 57(5):286-94. PubMed ID: 25241989
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
[TBL] [Abstract][Full Text] [Related]
6. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
Hou XH; Zhu YX; Lu HJ; Chen HF; Li Q; Jiang S; Xiang KS; Jia WP
J Gastroenterol Hepatol; 2011 Apr; 26(4):722-30. PubMed ID: 21418302
[TBL] [Abstract][Full Text] [Related]
8. Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population.
Meng G; Zhang B; Yu F; Li C; Zhang Q; Liu L; Wu H; Xia Y; Bao X; Shi H; Su Q; Gu Y; Fang L; Yang H; Yu B; Sun S; Wang X; Zhou M; Jia Q; Jiao H; Wang B; Guo Q; Carvalhoa LA; Sun Z; Song K; Yu M; Niu K
Eur J Nutr; 2018 Sep; 57(6):2113-2121. PubMed ID: 28702720
[TBL] [Abstract][Full Text] [Related]
9. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
[TBL] [Abstract][Full Text] [Related]
10. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.
Rivera-Andrade A; Kroker-Lobos MF; Lazo M; Freedman ND; Smith JW; Torres O; McGlynn KA; Groopman JD; Guallar E; Ramirez-Zea M
Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):191-200. PubMed ID: 30573307
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China.
Zhang H; He SM; Sun J; Wang C; Jiang YF; Gu Q; Feng XW; Du B; Wang W; Shi XD; Zhang SQ; Li WY; Niu JQ
Int J Med Sci; 2011 Mar; 8(3):254-62. PubMed ID: 21487569
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects.
Kim SS; Cho HJ; Kim HJ; Kang DR; Berry JR; Kim JH; Yang MJ; Lim SG; Kim S; Cheong JY; Cho SW
Dig Liver Dis; 2018 Apr; 50(4):370-377. PubMed ID: 29398414
[TBL] [Abstract][Full Text] [Related]
14. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
15. The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.
Zelber-Sagi S; Ben-Assuli O; Rabinowich L; Goldstein A; Magid A; Shalev V; Shibolet O; Chodick G
Liver Int; 2015 Nov; 35(11):2408-15. PubMed ID: 25845417
[TBL] [Abstract][Full Text] [Related]
16. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
Mohamed RZ; Jalaludin MY; Anuar Zaini A
J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
[TBL] [Abstract][Full Text] [Related]
17. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
18. A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study.
Farrell AM; Magliano DJ; Shaw JE; Thompson AJ; Croagh C; Ryan MC; Howell J
Sci Rep; 2022 Feb; 12(1):1956. PubMed ID: 35121749
[TBL] [Abstract][Full Text] [Related]
19. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
Yi M; Chen RP; Yang R; Chen H
Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.
Mansour-Ghanaei F; Joukar F; Mobaraki SN; Mavaddati S; Hassanipour S; Sepehrimanesh M
Diabetes Metab Syndr; 2019; 13(2):1591-1596. PubMed ID: 31336526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
